News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
855,743 Results
Type
Article (87072)
Company Profile (704)
Press Release (767952)
Multimedia
Podcasts (156)
Webinars (21)
Section
Business (232913)
Career Advice (4135)
Deals (39772)
Drug Delivery (131)
Drug Development (91152)
Employer Resources (200)
FDA (18219)
Job Trends (17377)
News (397040)
Policy (39862)
Tag
Academia (3002)
Academic (2)
Accelerated approval (15)
Adcomms (33)
Allergies (111)
Alliances (56978)
ALS (125)
Alzheimer's disease (1621)
Antibody-drug conjugate (ADC) (195)
Approvals (18195)
Artificial intelligence (421)
Autoimmune disease (39)
Automation (22)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (140)
Biotechnology (482)
Bladder cancer (110)
Brain cancer (44)
Breast cancer (416)
Cancer (3306)
Cardiovascular disease (264)
Career advice (3544)
Career pathing (34)
CAR-T (219)
CDC (43)
Cell therapy (605)
Cervical cancer (26)
Clinical research (74620)
Collaboration (1189)
Company closure (4)
Compensation (803)
Complete response letters (42)
COVID-19 (2923)
CRISPR (71)
C-suite (423)
Cystic fibrosis (126)
Data (3378)
Decentralized trials (2)
Denatured (56)
Depression (85)
Diabetes (392)
Diagnostics (7016)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (196)
Drug pricing (163)
Drug shortages (36)
Duchenne muscular dystrophy (171)
Earnings (98528)
Editorial (51)
Employer branding (25)
Employer resources (169)
Events (131765)
Executive appointments (935)
FDA (20290)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1066)
Gene editing (154)
Generative AI (42)
Gene therapy (477)
GLP-1 (970)
Government (5311)
Grass and pollen (7)
Guidances (323)
Healthcare (20921)
HIV (47)
Huntington's disease (32)
IgA nephropathy (48)
Immunology and inflammation (198)
Immuno-oncology (16)
Indications (43)
Infectious disease (3131)
Inflammatory bowel disease (171)
Inflation Reduction Act (13)
Influenza (81)
Intellectual property (142)
Interviews (813)
IPO (17911)
IRA (58)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (64)
Layoffs (612)
Leadership (27)
Legal (10141)
Liver cancer (87)
Longevity (12)
Lung cancer (460)
Lymphoma (234)
Machine learning (16)
Management (65)
Manufacturing (502)
MASH (111)
Medical device (14783)
Medtech (14795)
Mergers & acquisitions (22638)
Metabolic disorders (1010)
Multiple sclerosis (107)
NASH (23)
Neurodegenerative disease (166)
Neuropsychiatric disorders (48)
Neuroscience (2443)
NextGen: Class of 2025 (7687)
Non-profit (5093)
Now hiring (52)
Obesity (508)
Opinion (298)
Ovarian cancer (109)
Pain (137)
Pancreatic cancer (137)
Parkinson's disease (209)
Partnered (26)
Patents (354)
Patient recruitment (213)
Peanut (55)
People (65880)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23012)
Phase II (32389)
Phase III (24403)
Pipeline (2258)
Policy (265)
Postmarket research (3554)
Preclinical (10399)
Press Release (72)
Prostate cancer (161)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (558)
Real estate (7404)
Recruiting (76)
Regulatory (27432)
Reports (64)
Research institute (2667)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (13)
RSV (62)
Schizophrenia (112)
Series A (177)
Series B (128)
Service/supplier (30)
Sickle cell disease (71)
Special edition (23)
Spinal muscular atrophy (168)
Sponsored (38)
Startups (4310)
State (2)
Stomach cancer (17)
Supply chain (86)
Tariffs (77)
The Weekly (98)
Vaccines (963)
Venture capital (62)
Weight loss (349)
Women's health (53)
Worklife (20)
Date
Today (67)
Last 7 days (689)
Last 30 days (2636)
Last 365 days (33905)
2025 (21282)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (73)
Alaska (7)
Arizona (287)
Arkansas (14)
Asia (50652)
Australia (8899)
California (8402)
Canada (2565)
China (767)
Colorado (359)
Connecticut (375)
Delaware (226)
Europe (116304)
Florida (1260)
Georgia (286)
Hawaii (3)
Idaho (67)
Illinois (767)
India (36)
Indiana (408)
Iowa (19)
Japan (251)
Kansas (119)
Kentucky (34)
Louisiana (20)
Maine (75)
Maryland (1169)
Massachusetts (6384)
Michigan (286)
Minnesota (519)
Mississippi (4)
Missouri (109)
Montana (32)
Nebraska (26)
Nevada (93)
New Hampshire (75)
New Jersey (2330)
New Mexico (31)
New York (2313)
North Carolina (1301)
North Dakota (10)
Northern California (3693)
Ohio (268)
Oklahoma (17)
Oregon (48)
Pennsylvania (1790)
Puerto Rico (18)
Rhode Island (42)
South America (1654)
South Carolina (39)
South Dakota (1)
Southern California (3154)
Tennessee (136)
Texas (1308)
United States (31459)
Utah (247)
Virginia (228)
Washington D.C. (80)
Washington State (726)
West Virginia (4)
Wisconsin (89)
There are 855,743 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Anixa Biosciences Announces Treatment of Second Patient in Fourth Cohort of Ovarian Cancer CAR-T Clinical Trial
August 19, 2025
·
4 min read
Press Releases
IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes
August 19, 2025
·
4 min read
Press Releases
Avixgen, a subsidiary of Dx&Vx, signs a licensing-out agreement worth USD 360 million with a U.S. biotech company for its next-generation drug delivery platform (ACP).
August 19, 2025
·
3 min read
Press Releases
Novo Nordisk lowers cost of Ozempic® to $499 per month for self-paying patients, in support of patient access to authentic, FDA-approved semaglutide medicines
August 19, 2025
·
15 min read
Press Releases
Co-Diagnostics, Inc. to Host Booth at 17th Next Generation Dx Summit in Washington, D.C.
August 19, 2025
·
2 min read
Press Releases
jCyte Inc. Announces First Patients Treated in JC02-88 Trial for Retinitis Pigmentosa
August 19, 2025
·
3 min read
Press Releases
bioAffinity Technologies Appoints New Members to Board of Directors
August 19, 2025
·
5 min read
Press Releases
Cohesys Announces First-in-Human Use of Investigational BoneTape™ in Craniofacial Fracture Repair
August 19, 2025
·
2 min read
Press Releases
Alto Neuroscience to Participate in Upcoming Investor Conferences - August 18, 2025
August 19, 2025
·
2 min read
Press Releases
PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors
August 19, 2025
·
3 min read
1 of 85,575
Next
